Table 2.
Cell line | Accession | Platform | Sample number |
---|---|---|---|
ATO treatment | |||
ASPC1 | GSE124069 | GPL570 | 1 control, 3 case |
PANC1 | GSE124069 | GPL570 | 1 control, 3 case |
BXPC3 | GSE124069 | GPL570 | 1 control, 4 case |
MIApaca | GSE124069 | GPL570 | 1 control, 4 case |
U266 | GSE14519 | GPL570 | 2 control, 3 case |
MM.1s | GSE14519 | GPL570 | 2 control, 3 case |
KMS11 | GSE14519 | GPL570 | 2 control, 3 case |
8226/S | GSE14519 | GPL570 | 2 control, 3 case |
BEAS-2B | GSE33520 | GPL6480 | 4 control, 3 case |
Jurkat | GSE46909 | GPL16311 | 4 control, 4 case |
HepG2 | GSE48441 | GPL201 | 3 control, 15 case |
HepG2 | GSE6907 | GPL201 | 3 control, 3 case |
MEC-1 | GSE78207 | GPL16987 | 3 control, 3 case |
HepG2 | GSE8865 | GPL201 | 3 control, 3 case |
hESC | GSE94521 | GPL570 | 5 control, 5 case |
K562 | GSE104813 | GPL10332 | 1 control, 1 case |
KU-812 | GSE104813 | GPL10332 | 1 control, 1 case |
MEG-A2 | GSE104813 | GPL10332 | 1 control, 1 case |
ATRA treatment | |||
HL-60 | GSE34726 | GPL10558 | 6 control, 6 case |
NB4 | GSE23702 | GPL6244 | 3 control, 6 case |
HL-60 | GSE5007 | GPL96 | 3 control, 3 case |